Literature DB >> 32551904

Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update.

Anthony Ciarallo1, Juan Rivera2.   

Abstract

OBJECTIVE. The paradigm of theranostics is based on tailoring therapy for the purpose of optimizing outcomes. This principle is being applied to radioactive iodine therapy. Consequently, thyroid cancer therapy protocols are evolving. The purpose of this article is to promote a modern approach to radioiodine therapy. CONCLUSION. This article highlights guidelines and position statements, summarizes the prognostication systems of thyroid cancer, and reviews which prescribed activities of 131I.

Entities:  

Keywords:  DTC; I-131; RAI; differentiated thyroid cancer; radioactive iodine therapy; thyroid cancer

Mesh:

Substances:

Year:  2020        PMID: 32551904     DOI: 10.2214/AJR.19.22626

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer.

Authors:  Lina Liu; Yuhong Shi; Qian Lai; Yuan Huang; Xue Jiang; Qian Liu; Ying Huang; Yuxiao Xia; Dongkun Xu; Zhiqiang Jiang; Wenling Tu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-11       Impact factor: 6.055

2.  Effectiveness and Safety of Levothyroxine Tablets Combined with Iodine-131 in the Treatment of Thyroid Cancer.

Authors:  Yang Bai; Jian Jin; Yonghong Liu; Buyong Zhang; Bo Zhang; Jie Li
Journal:  J Oncol       Date:  2022-06-02       Impact factor: 4.501

3.  Evaluation of Diagnostic Value of SPECT/CT Imaging in Post-radioiodine Therapy in Thyroid Cancer.

Authors:  Asma Al Hatmi; Anjali Jain; Alok K Mittal; Samir Hussain
Journal:  Sultan Qaboos Univ Med J       Date:  2022-02-28

Review 4.  Theranostic nanoparticles for the management of thrombosis.

Authors:  Peije Russell; Christoph Eugen Hagemeyer; Lars Esser; Nicolas Hans Voelcker
Journal:  Theranostics       Date:  2022-03-14       Impact factor: 11.600

Review 5.  Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer.

Authors:  Massimiliano Pacilio; Miriam Conte; Viviana Frantellizzi; Maria Silvia De Feo; Antonio Rosario Pisani; Andrea Marongiu; Susanna Nuvoli; Giuseppe Rubini; Angela Spanu; Giuseppe De Vincentis
Journal:  Diagnostics (Basel)       Date:  2022-07-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.